TipRanks Cyber Monday Sale
- Claim 60% off TipRanks Premium for data-backed insights and research tools you need to invest with confidence.
- Subscribe to TipRanks' Smart Investor Picks and see our data in action through our high-performing model portfolio - now also 60% off
An announcement from Elite Pharmaceuticals ( (ELTP) ) is now available.
Elite Pharmaceuticals has launched a generic version of Norco®, a prominent pain management drug, potentially tapping into a lucrative market with reported annual sales of $300 million. This move underscores Elite’s strategy to focus on niche generic products, leveraging its specialized manufacturing facilities in New Jersey to produce both immediate and controlled-release oral dose medications.
For a thorough assessment of ELTP stock, go to TipRanks’ Stock Analysis page.